
De novo synthesis of β-carotene
We successfully introduced a synthetic β-carotene biosynthetic pathway into Saccharomyces cerevisiae with CRISPR-Cas9 genome editing to enable the de novo synthesis of β-carotene. The β-carotene titer produced by S. cerevisiae in shake-flask fermentation reached 129.1 mg/L.
Saccharomyces cerevisiae
-Well-defined genetics
-Easy to culture
-Proven safety in both food and pharmaceutical applications
Compartmentalization strategy
We successfully developed and optimized a spatial metabolic engineering toolkit tolocalize enzymes to lipid droplets - natural reservoirs for lipophilic compounds. Byfusing this LD-targeting toolkit with key genes (carB and carRP), we achieved precisesubcellular localization, significantly enhancing pathway efficiency and boosting β-carotene production to 318.4 mg/L in shake flasks.
Scale-Up Fermentation & Real-Time Colorimetric Device
We successfully scaled up β-carotene production to 1.8g/L in 5L bioreactors using an optimized fed-batch fermentation strategy. To enable real-time yield estimation, we developed a colorimetric monitoring device that predicts β-carotene levels based on culture color intensity. This non-destructive, low-cost tool allows efficient process tracking and can be applied to other pigment-producing systems for automated fermentation control.
10 days